TGFB1 and cancer: Identification of the IL-1β/Glo1/MG-H1/TGF-β1/FAK axis in ATC cell aggressiveness suggests that IL-1β and Glo1, which orchestrate the mechanism, may represent novel potential therapeutic targets for ATC, which remains one of the most lethal human cancers [46].